These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29856191)

  • 41. Treatment of neuropathic pain with 5% lidocaine-medicated plaster: Five years of clinical experience.
    Delorme C; Navez ML; Legout V; Deleens R; Moyse D
    Pain Res Manag; 2011; 16(4):259-63. PubMed ID: 22059196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness, Safety, and Predictors of Response to 5% Lidocaine-Medicated Plaster for the Treatment of Patients With Trigeminal Neuralgia: A Retrospective Study.
    Yu B; Zhang W; Zhao C; Xing Y; Meng L; Luo F
    Ann Pharmacother; 2023 May; 57(5):527-534. PubMed ID: 36039508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.
    Rowbotham MC; Davies PS; Verkempinck C; Galer BS
    Pain; 1996 Apr; 65(1):39-44. PubMed ID: 8826488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of lidocaine in patients receiving palliative care with opioid-refractory cancer pain with a neuropathic component: study protocol for a randomized controlled study.
    Salas S; Auquier P; Duffaud F; Garnier SR; Deschamps M; Honoré S; Sudour P; Baumstarck K
    Trials; 2014 Aug; 15():318. PubMed ID: 25112302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.
    Gudin J; Nalamachu S
    Postgrad Med; 2020 Jan; 132(1):28-36. PubMed ID: 31900074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Postherpetic Neuralgia with 5% Topical Lidocaine Plaster – Experience from a Small County Hospital: Case Report.
    Kontić M; Vičić-Hudorović V; Hudorović N
    Acta Clin Croat; 2016 Dec; 55(4):655-658. PubMed ID: 29117658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia.
    Kanai A; Suzuki A; Kobayashi M; Hoka S
    Br J Anaesth; 2006 Oct; 97(4):559-63. PubMed ID: 16882684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of acute and chronic focal neuropathic pain in cancer patients with lidocaine 5 % patches. A radiation and oncology department experience.
    López Ramírez E
    Support Care Cancer; 2013 May; 21(5):1329-34. PubMed ID: 23242387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster.
    Casale R; Mattia C
    Ther Clin Risk Manag; 2014; 10():259-68. PubMed ID: 24790451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive function in older patients with postherpetic neuralgia.
    Pickering G; Pereira B; Clère F; Sorel M; de Montgazon G; Navez M; Picard P; Roux D; Morel V; Salimani R; Adda M; Legout V; Dubray C
    Pain Pract; 2014 Jan; 14(1):E1-7. PubMed ID: 23701810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. More than 7 years of consistent neuropathic pain relief in geriatric patients.
    Galer BS; Gammaitoni AR
    Arch Intern Med; 2003 Mar; 163(5):628. PubMed ID: 12622611
    [No Abstract]   [Full Text] [Related]  

  • 52. Thiamine, cobalamin, locally injected alone or combination for herpetic itching: a single-center randomized controlled trial.
    Xu G; Lv ZW; Xu GX; Tang WZ
    Clin J Pain; 2014 Mar; 30(3):269-78. PubMed ID: 23887347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lidocaine 700 mg medicated plaster for post-herpetic neuralgia: focus on Quality of Life, effectiveness and safety - a retrospective observational study.
    Giaccari LG; Aurilio C; Coppolino F; Pace MC; Passavanti MB; Pota V; Sansone P
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):130-137. PubMed ID: 35049028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical Lidocaine for Chronic Pain Treatment.
    Voute M; Morel V; Pickering G
    Drug Des Devel Ther; 2021; 15():4091-4103. PubMed ID: 34616143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?
    Kern KU; Nowack W; Poole C
    Pain Pract; 2014 Feb; 14(2):E42-50. PubMed ID: 24289500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch].
    Meier T; Faust M; Hüppe M; Schmucker P
    Schmerz; 2004 Jun; 18(3):172-8. PubMed ID: 15221421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study.
    Devers A; Galer BS
    Clin J Pain; 2000 Sep; 16(3):205-8. PubMed ID: 11014393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial.
    Palladini M; Boesl I; Koenig S; Buchheister B; Attal N
    Curr Med Res Opin; 2019 May; 35(5):757-766. PubMed ID: 30614286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous lidocaine infusions in a multidirectional model of treatment of neuropathic pain patients.
    Przeklasa-Muszyńska A; Kocot-Kępska M; Dobrogowski J; Wiatr M; Mika J
    Pharmacol Rep; 2016 Oct; 68(5):1069-75. PubMed ID: 27552062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.